Pharmacogenomics

Papers
(The H4-Index of Pharmacogenomics is 11. The table below lists those papers that are above that threshold based on CrossRef citation counts [max. 250 papers]. The publications cover those that have been published in the past four years, i.e., from 2022-06-01 to 2026-06-01.)
ArticleCitations
Identification of RNA Modification-Associated Single-Nucleotide Polymorphisms in Genomic Loci for Low-Density Lipoprotein Cholesterol Concentrations45
Patient comprehension of preemptive pharmacogenomic results28
Pharmacogenomic variants affecting efficacy and safety of medicines acting on central nervous system among Sri Lankans27
How to implement pre-emptive pharmacogenetic testing in the acute hospital setting25
Whole exome sequencing identifies rare variants involved in PPIX-metabolizing pathway in anti-TB drug-induced hepatitis19
Evidence level for pharmacogenetic testing in antidepressant treatment: a systematic review15
miR-369-3p regulates the drug resistance of lung cancer cells by targeting PTPN1215
Genetics and response to treatment with metformin for type 2 diabetes13
Assessing patient understanding of pharmacogenomic test results: a qualitative study13
Pharmacogenomics for Prader-Willi syndrome: caregiver interest and planned utilization12
Pharmacogenomics in Psychiatry – the Challenge of Cytochrome P450 Enzyme Phenoconversion and Solutions to Assist Precision Dosing12
Rapid point of care testing: the next frontier in pharmacogenomics11
Genetics of tardive dyskinesia: a review of progress over the past decade11
A systematic review of single nucleotide polymorphisms affecting allopurinol pharmacokinetics and serum uric acid level11
Characterization of CYP2C19 Pharmacogenetic Variation in African Populations and Comparison with Other Global Populations11
0.12412095069885